1. Rituximab versus natalizumab, fingolimod, and dimethyl fumarate in multiple sclerosis treatment. Issue 9 (6th August 2020) Authors: Vollmer, Brandi L.; Nair, Kavita; Sillau, Stefan; Corboy, John R.; Vollmer, Timothy; Alvarez, Enrique Journal: Annals of clinical and translational neurology Issue: Volume 7:Issue 9(2020) Page Start: 1466 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗